TrialBone marrow transplantation2013

Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients.

N Kröger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.